Cite
Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC.
MLA
Erdat, Efe Cem, et al. “Enhancing the Anti-Angiogenic Effect of Bevacizumab with ACE Inhibition on MCRC.” Journal of Gastrointestinal Cancer, vol. 54, no. 3, Sept. 2023, pp. 897–902. EBSCOhost, https://doi.org/10.1007/s12029-022-00890-4.
APA
Erdat, E. C., Koksoy, E. B., & Utkan, G. (2023). Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC. Journal of Gastrointestinal Cancer, 54(3), 897–902. https://doi.org/10.1007/s12029-022-00890-4
Chicago
Erdat, Efe Cem, Elif Berna Koksoy, and Gungor Utkan. 2023. “Enhancing the Anti-Angiogenic Effect of Bevacizumab with ACE Inhibition on MCRC.” Journal of Gastrointestinal Cancer 54 (3): 897–902. doi:10.1007/s12029-022-00890-4.